<!DOCTYPE html>
<!--[if lt IE 7]>      <html class="no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]-->
<!--[if IE 7]>         <html class="no-js lt-ie9 lt-ie8"> <![endif]-->
<!--[if IE 8]>         <html class="no-js lt-ie9"> <![endif]-->
<!--[if gt IE 8]><!--><html class="no-js"> <!--<![endif]-->
    <head>
        <meta charset='utf-8'>
        <meta http-equiv='X-UA-Compatible' content='IE=edge,chrome=1'>
        <title>DC Code - § 48–831.02. Definitions.</title>
        <meta property='st:title' content='§ 48–831.02. Definitions.' />
        <meta name='description' content='A simple, free browser for the Washington, DC Code'>
        <meta name='viewport' content='width=device-width'>
        <link href='http://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,400,700' rel='stylesheet' type='text/css'>
        <link rel='stylesheet' type='text/css' href='/css/reset.css' media='screen' />
        <link rel='stylesheet' type='text/css' href='/css/site.css' media='screen' />
        <link rel='stylesheet' type='text/css' href='/css/body.css' media='screen' />
        <link rel='stylesheet' type='text/css' href='/css/print.css' media='print' />
        <link rel='stylesheet' type='text/css' href='/css/icons/style.css' media='screen' />
    </head>
    <body>
            <header>
                <div class="container">
                <div class='right no-print'>
                    <form id='search-form'>
                        <form>
                            <input type="text" id="st-search-input" class="st-default-search-input" />
                        </form>
                    </form>
                </div>
                <h1 id='sitename'><a href='/'>Code of the District of Columbia (Unofficial)</a></h1>
            </div>
            </header>
            <div class='main container'>
                <div class='clearfix' style='width: 100%;'>
                    <div id='sidebar' class='col4 quiet'>
                        
                            <h2>You Are Here</h2>
                            <ul class="ancestors">
                            
                                <li><a href='/'>Code of the District of Columbia</a></li>
                            
                                <li>↪ <a href='/Title-48/'>Title 48. Foods and Drugs.</a></li>
                            
                                <li>↪ <a href='/Title-48/Chapter-8A/'>Chapter 8A. Affordability of Prescription Drugs — AccessRx Program.</a></li>
                            
                                <li>↪ <a href='/Title-48/Chapter-8A/Subchapter-I/'>Subchapter I. AccessRx.</a></li>
                            
                                <li>↪ <a href='/Title-48/Chapter-8A/Subchapter-I/Part-A/'>Part A. General.</a></li>
                            
                            <li>↪ § 48–831.02. Definitions.</a></li>
                            </ul>
                        

                        
                            <h2>Previous</h2>
                            <p><a href="/sections/48-831.01.html">§ 48–831.01. Findings and declaration of intent.</a></p>
                        

                        
                            <h2>Next</h2>
                            <p><a href="/sections/48-831.03.html">§ 48–831.03. Establishment of AccessRx.</a></p>
                        

                        <h2>Publication Information</h2>
                        <h3>Current through April 13, 2015</h3>
                        <dl id="recency">
                            <dt>Last codified D.C. Law:</dt>
                            <dd>Law 20-241 effective April 13, 2015</dd>
                            <dt>Last codified Emergency Law:</dt>
                            <dd>Act 20-617 effective January 28, 2015</dd>
                            <dt>Last codified Federal Law:</dt>
                            <dd>Public Law 113-235 approved December 16, 2014</dd>
                        </dl>
                    </div>
                    <div class='col8'>
                        <div id='content'>
                            <div class="line-group line-group-page-heading">
    <h1 data-swiftype-index='true'>§ 48–831.02. Definitions.</h1>
</div>

<div data-swiftype-index='true'>

    
        

    

    

    <div class="line-group primary-content ">
        

    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">For the purposes of this chapter, the term:</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(1) </span>
                
                    <span class="" style="">“AccessRx” means the District of Columbia AccessRx program established by <a href='/sections/48-831.03.html'>§ 48‑831.03</a>.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(2) </span>
                
                    <span class="" style="">“Average wholesale price” means the wholesale price charged for a specific commodity that is assigned by the drug wholesaler and is listed in a nationally recognized drug pricing registry that is updated daily and charged to the retail pharmacy.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(3) </span>
                
                    <span class="" style="">“Basic component of AccessRx” includes the provision of drugs and medications for cardiac conditions and high blood pressure, diabetes, arthritis, anticoagulation, hyperlipidemia, osteoporosis, chronic obstructive pulmonary disease and asthma, incontinence, thyroid diseases, glaucoma, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and other conditions approved by the Department. The term “basic component of AccessRx” shall also include the provision of over-the-counter medications that are prescribed by a health care provider and approved as cost-effective by the Department.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(4) </span>
                
                    <span class="level-num" style="">(A) </span>
                
                    <span class="" style="">“Covered entity” means:</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 3.75em">
            
                <p>
                
                    <span class="level-num" style="">(i) </span>
                
                    <span class="" style="">Any hospital or medical service organization, insurer, health coverage plan, or health maintenance organization licensed in the District that contracts with another entity to provide prescription drug benefits for its customers or clients;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 3.75em">
            
                <p>
                
                    <span class="level-num" style="">(ii) </span>
                
                    <span class="" style="">Any health program administered by the Department or the District in its capacity as provider of health coverage; or</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 3.75em">
            
                <p>
                
                    <span class="level-num" style="">(iii) </span>
                
                    <span class="" style="">Any employer, labor union, or other group of persons organized in the District that contracts with another entity to provide prescription drug benefits for its employees or members who are employed or reside in the District of Columbia.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(B) </span>
                
                    <span class="" style="">The term “covered entity” does not include a health plan that provides coverage only for accidental injury, specified disease, hospital indemnity, Medicare supplement, disability income, long-term care, or other limited benefit health insurance policies and contracts.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(5) </span>
                
                    <span class="" style="">“Covered individual” means a member, participant, enrollee, contract holder, policy holder, or beneficiary of a covered entity who is provided a prescription drug benefit by the covered entity. The term “covered individual” includes a dependent or other person provided a prescription drug benefit through a policy, contract, or plan for a covered individual.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(6) </span>
                
                    <span class="" style="">“Department” means the Department of Health.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(7) </span>
                
                    <span class="" style="">“Director” means the Director of the Department of Health.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(8) </span>
                
                    <span class="" style="">“District” means the District of Columbia.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(9) </span>
                
                    <span class="" style="">“Generic drug” means a chemically equivalent copy of a brand-name drug with an expired patent.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(10) </span>
                
                    <span class="" style="">“Initial discounted price” for a drug means the price the Department pays D.C. Medicaid participating retail pharmacies for that drug for District of Columbia Medicaid recipients.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(11) </span>
                
                    <span class="" style="">“Labeler” means an entity or person that receives prescription drugs from a manufacturer or wholesaler and repackages those drugs for later retail sale and that has a labeler code from the federal Food and Drug Administration under 21 C.F.R. § 207.20.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(12) </span>
                
                    <span class="" style="">“Manufacturer” means a manufacturer of prescription drugs and includes a subsidiary or affiliate of a manufacturer.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(13) </span>
                
                    <span class="" style="">“Marketing” means advertising and promotional activities, including, but not limited to, the activities described in <a href='/sections/48-833.03.html'>§ 48‑833.03</a>.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(14) </span>
                
                    <span class="" style="">“National Drug Code registration number” means the number registered for a drug pursuant to the listing system established by the United States Food and Drug Administration under section 510 of the Federal Food, Drug, and Cosmetic Act, approved October 10, 1962 (<a href='http://api.fdsys.gov/link?collection=statute&volume=76&page=794'>76 Stat. 794</a>; 21 U.S.C. § 360).</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(15) </span>
                
                    <span class="" style="">“Participating retail pharmacy” or “retail pharmacy” means a retail pharmacy located in the District, or another business licensed to dispense prescription drugs in the District, that participates in the program.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(16) </span>
                
                    <span class="" style="">“Pharmacy benefits management” means a service provided to covered entities to facilitate the provision of prescription drug benefits to covered individuals for dispensation within the District of Columbia, including negotiating pricing and other terms with drug manufacturers and retails pharmacies. “Pharmacy benefits management” may include any or all of the following:</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(A) </span>
                
                    <span class="" style="">Claims processing, retail network management, and payment of claims to pharmacies for prescription drugs dispensed to covered individuals for dispensation within the District of Columbia;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(B) </span>
                
                    <span class="" style="">Clinical formulary development and management services;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(C) </span>
                
                    <span class="" style="">Rebate contracting and administration;</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(D) </span>
                
                    <span class="" style="">Certain patient compliance, therapeutic intervention, and generic substitution programs; and</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 2.5em">
            
                <p>
                
                    <span class="level-num" style="">(E) </span>
                
                    <span class="" style="">Disease management programs.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(17) </span>
                
                    <span class="" style="">“Pharmacy benefits manager” means an entity that performs pharmacy benefits management. The term “pharmacy benefits manager” includes a person or entity acting for a pharmacy benefits manager in a contractual or employment relationship in the performance of pharmacy benefits management for a covered entity.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(18) </span>
                
                    <span class="" style="">“Qualified resident” means a resident of the District who is eligible for the AccessRx program pursuant to this subchapter.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(19) </span>
                
                    <span class="" style="">“Secondary discounted price” means the initial discounted price minus any further discounts paid for out of the AccessRx Fund.</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="level-num" style="">(20) </span>
                
                    <span class="" style="">“Supplemental component of AccessRx” includes all prescription drugs and medications provided under the D.C. Medicaid program excluding those provided pursuant to the basic component of AccessRx.</span>
                
                </p>
            
        </div>
    

    </div>

    <div class="line-group annotations ">
        

    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">History</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">(May 18, 2004, <a href='http://openlims.org/public/L15-164.pdf'>D.C. Law 15-164</a>, § 102, 51 DCR 3688; Mar. 2, 2007, <a href='http://openlims.org/public/L16-192.pdf'>D.C. Law 16-192</a>, § 5062(a), 53 DCR 6899.)</span>
                
                </p>
            
        </div>
    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">Effect of amendments</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style=""><a href='http://openlims.org/public/L16-192.pdf'>D.C. Law 16-192</a>, in par. (4)(A)(iii), substituted “for its employees or members who are employed or reside in the District of Columbia” for “for its employees or members”; and, in par. (16), substituted “to covered individuals for dispensation within the District of Columbia” for “to covered individuals”.</span>
                
                </p>
            
        </div>
    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">Temporary Amendment of Section</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">For temporary (225 day) amendment of section, see § 2(a) of AccessRx Act Clarification Temporary Amendment of Act of 2006 (<a href='http://openlims.org/public/L16-154.pdf'>D.C. Law 16-154</a>, September 19, 2006, law notification  53 DCR 7926).</span>
                
                </p>
            
        </div>
    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">Emergency legislation</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">For temporary (90 day) amendment of section, see § 2(a) of AccessRX Act Clarification Emergency Amendment Act of 2006 (D.C. Act 16-370, May 5, 2006,  53 DCR 4059).</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">For temporary (90 day) amendment of section, see § 5062(a) of Fiscal Year 2007 Budget Support Emergency Act of 2006 (D.C. Act 16-477, August 8, 2006,  53 DCR 7068).</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">For temporary (90 day) amendment of section, see § 5062(a) of Fiscal Year 2007 Budget Support Congressional Review Emergency Act of 2006 (D.C. Act 16-499, October 23, 2006,  53 DCR 8845).</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">For temporary (90 day) amendment of section, see § 5062(a) of Fiscal Year 2007 Budget Support Congressional Review Emergency Act of 2007 (D.C. Act 17-1, January 16, 2007,  54 DCR 1165).</span>
                
                </p>
            
        </div>
    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">Legislative history of Law 15-164</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">For <a href='http://openlims.org/public/L15-164.pdf'>Law 15-164</a>, see notes following <a href='/sections/48-831.01.html'>§ 48‑831.01</a>.</span>
                
                </p>
            
        </div>
    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">Legislative history of Law 16-192</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style=""><a href='http://openlims.org/public/L16-192.pdf'>Law 16-192</a>, the “Fiscal Year Budget Support Act of 2006”, was introduced in Council and assigned Bill No. 16-679, which was referred to the Committee of the Whole. The Bill was adopted on first and second readings on May 9, 2006, and June 6, 2006, respectively. Signed by the Mayor on August 8, 2006, it was assigned Act No. 16-476 and transmitted to both Houses of Congress for its review. <a href='http://openlims.org/public/L16-192.pdf'>D.C. Law 16-192</a> became effective on March 2, 2007.</span>
                
                </p>
            
        </div>
    
        <div class="line subheading " style="text-indent: 0em">
            
                <p>
                
                    <span class="" style="">Short title</span>
                
                </p>
            
        </div>
    
        <div class="line  " style="text-indent: 1.25em">
            
                <p>
                
                    <span class="" style="">Short title: Section 5061 of <a href='http://openlims.org/public/L16-192.pdf'>D.C. Law 16-192</a> provided that subtitle F of title V of the act may be cited as the “AccessRx Clarification Amendment Act of 2006”.</span>
                
                </p>
            
        </div>
    

    </div>

</div>

                        </div>
                    </div>
                </div>
            </div>
            <footer>
                <div class='container center'>
                    <p>
                        <a href='https://github.com/dccouncil/simple-generator/issues'>See a problem? Report an issue.</a>
                        <a href='http://swiftype.com?ref=pb'>Search provided by Swiftype.</a>
                    </p>
                </div>
            </footer>
        </div>
        <script type="text/javascript">
          (function(w,d,t,u,n,s,e){w['SwiftypeObject']=n;w[n]=w[n]||function(){
          (w[n].q=w[n].q||[]).push(arguments);};s=d.createElement(t);
          e=d.getElementsByTagName(t)[0];s.async=1;s.src=u;e.parentNode.insertBefore(s,e);
          })(window,document,'script','//s.swiftypecdn.com/install/v2/st.js','_st');

          _st('install','NgdhbkD2KjyeSy3wWRri','2.0.0');
        </script>
    </body>
</html>
